Flexion Therapeutics (FLXN) Stock Price, Quote & News

Company Profile

The fund is an actively managed ETF that seeks to achieve its investment objective by investing primarily in non-investment grade Fixed Income Instruments. The fund’s Fixed Income Instruments may include debt or debt-related securities, income producing securities, and other instruments or evidences of indebtedness, including bonds, bills, notes, loans, money market instruments, mortgage and asset backed securities, and preferred stocks, and derivative instruments related thereto; and other inve...

Phone: (704) 544-2399

AlphaTuna Dec. 9 at 11:28 PM

Highest Volume Rated ETFs Per 12/9/2025’s Close: 1 – $CIL 2 – $TMAR 3 – $BMDL 4 – $DWUS 5 – $FLXN 6 – $HBTA 7 – $TGRW 8 – $LLDR 9 – $MCDS 10 – $JHMD https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-12-9-2025/

0 · Reply

GreenFlicker Sep. 15 at 9:19 AM

$FLXN Catalyst-driven outlook; upcoming catalysts could re-rate valuation

0 · Reply

UltraInstinct Jun. 29 at 2:14 AM

$FLXN was the first stock I ever bought back in 2015 and looks like nothing changed in 9 years. Its at the same fucking price 😓

1 · Reply

ModernWorldNews Apr. 17 at 4:47 AM

$FLXN modernworldnews.com - Flexion Therapeutics is a biopharmaceutical company focused on developing innovative solutions for musculoskeletal disorders. Why did the skeleton refuse to go to the party? He had nobody to dance with! Flexion Therapeutics could have a bone-rattling good run in the future.

0 · Reply

MoonShot77 Apr. 6 at 4:28 PM

$CYDY Held a couple biotechs into FDA catalysts. Both $PTLA and $FLXN went down in the days prior to a positive FDA outcome. On the flipside also been in a few that ramped into Fda catalysts only to see a negative outcome. This is nothing but a buying opportunity, I expect a great conference call. King Cyrus the Great is about to free us from the evils of FDA Babylon. Extremely

1 · Reply